This inventor holds 1 USPTO granted patent. Top assignee: Mbd Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Do Hyeong Na: Innovator in Metabolic Disease Treatment
Introduction
Do Hyeong Na is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target metabolic diseases. His innovative work has the potential to impact the treatment of various health conditions.
Latest Patents
Do Hyeong Na holds a patent for "Heterocyclic CYP4A inhibitor compounds and compositions thereof." This invention relates to a novel quinoline or quinazoline compound that exhibits excellent inhibitory activity against cytochrome P450 4A (CYP4A). The compound may be utilized for preventing, relieving, or treating metabolic diseases, showcasing its therapeutic potential.
Career Highlights
He is currently associated with Mbd Co., Ltd., where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Bo Sung Ku and Ho Sang Moon. Their collaborative efforts contribute to the success of their projects and the advancement of their research.
Conclusion
Do Hyeong Na's contributions to the field of medicinal chemistry, particularly through his patent on CYP4A inhibitors, highlight his role as an innovator in the treatment of metabolic diseases. His work continues to pave the way for future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile